封面
市场调查报告书
商品编码
1490168

睡眠辅助市场:依产品类型、睡眠障碍、地区

Sleep Aids Market, By Product Type, By Sleep Disorder, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 187 Pages | 商品交期: 2-3个工作天内

价格
简介目录

根据预测,2024年全球睡眠辅助市场规模将达到776.8亿美元,2024年至2031年年复合成长率(CAGR)为7.6%,2031年将达1,295.8亿美元。

报告范围 报告详情
基准年 2023年 2024年市场规模 776.8亿美元
实际资料 2019年至2023年 预测期 从2024年到2031年
预测 2024-2031 年复合年增长率: 7.60% 2031年价值预测 1295.8亿美元
图:2024 年睡眠辅助产品市场占有率(%),依地区划分
睡眠辅助市场-IMG1

由于睡眠障碍的盛行率不断增加,全球睡眠辅助市场在过去几年中稳步增长。压力水平上升、生活方式的改变和人口老化已成为失眠和其他睡眠障碍的主要因素。此外,人们越来越意识到睡眠不足对健康和生产力的负面影响,并且越来越多的人正在寻求治疗。市面上有各种安眠药和睡眠设备可以帮助人们获得充分的休息。随着人们健康意识的增强,草药和补充品等更多天然产品也越来越受欢迎,以促进睡眠。由于持续的研究和开发带来的创新以及新兴国家不断增长的需求,预计睡眠辅助市场在未来几年将进一步显着增长。

市场动态:

全球睡眠辅助市场主要是由于饮食变化、忙碌的生活方式和压力水平增加导致的睡眠障碍盛行率上升所推动的。睡眠不足与许多健康问题有关,包括肥胖、心臟病和忧郁症,这推动了睡眠辅助剂的采用。此外,容易出现睡眠障碍的老年人数量不断增加,也成为产业企业需要应对的庞大市场。然而,与处方安眠药相关的副作用和风险已成为主要问题。许多国家对替代疗法的偏好也在一定程度上阻碍了市场收益的成长。与此同时,睡眠技术(包括穿戴式装置和行动应用程式)的创新步伐正在提供新的机会。新兴国家对失眠影响的认识不断提高以及医疗基础设施的改善将进一步支持未来的产业扩张。

本研究的主要特点

  • 该报告对全球睡眠辅助市场进行了详细分析,并提供了以 2023 年为基准年的预测期(2024-2031 年)的市场规模(十亿美元)和年复合成长率(CAGR%)。
  • 它还强调了各个细分市场的潜在收益成长机会,并说明了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
  • 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数,介绍了全球睡眠辅助市场的主要企业。
  • 主要企业包括 Pfizer、GSK plc、Sommetrics, Inc.、Cadwell Industries, Inc.、SleepMed, Inc.、Natus Medical Incorporated、Therapix Biosciences Ltd.、Compumedics Limited、 Eisai、Tris Pharma, Inc.、Novartis AG、Idorsia Pharmaceuticals Ltd.、ResMed 和阿斯特捷利康。
  • 该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球睡眠辅助市场迎合了该行业的各种相关人员,如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员可以透过分析全球睡眠辅助市场时所使用的各种策略矩阵来促进他们的决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章 市场动态、法规与趋势分析

  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 主要进展
  • 监管场景
  • 製造商收益
  • 收购和合作场景
  • 产品发布/核准
  • 资金筹措和投资
  • PEST分析
  • 波特的分析

第四章全球睡眠辅助市场 - 冠状病毒 (COVID-19) 大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 对市场的影响

第五章全球睡眠辅助市场,依产品类型,2019-2031

  • 药品
  • 睡眠呼吸中止症装置
  • 床垫和枕头
  • 其他的

第六章 全球睡眠辅助市场,依睡眠障碍分类,2019-2031 年

  • 失眠
  • 睡眠呼吸中止症
  • 不宁腿
  • 夜惊
  • 其他的

第七章 全球睡眠辅助市场,依地区,2019-2031

第八章 竞争格局

  • 公司简介
    • Pfizer Inc.
    • GSK plc
    • Sommetrics, Inc.
    • Cadwell Industries, Inc.
    • SleepMed, Inc.
    • Natus Medical Incorporated
    • Therapix Biosciences Ltd
    • Compumedics Limited
    • Eisai Co., Ltd.
    • Tris Pharma, Inc.
    • Novartis AG
    • Idorsia Pharmaceuticals Ltd.
    • ResMed
    • AstraZeneca

第九章 分析师观点

  • Wheel of Fortune
  • 分析师观点
  • Coherent Opportunity Map

第10章 参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI1059

The global sleep aids market is estimated to be valued at USD 77.68 Bn in 2024 and is expected to reach USD 129.58 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 7.6% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 77.68 Bn
Historical Data for: 2019 To 2023 Forecast Period: 2024 To 2031
Forecast Period 2024 to 2031 CAGR: 7.60% 2031 Value Projection: US$ 129.58 Bn
Figure. Sleep Aids Market Share (%), By Region, 2024
Sleep Aids Market - IMG1

The global sleep aids market has been witnessing steady growth in the last few years owing to the increasing prevalence of sleep disorders. Rising stress levels, changing lifestyles, and growing aging population have emerged as major factors fueling insomnia and other sleep disorders. Moreover, growing awareness about the ill-effects of sleep deprivation on health and productivity are prompting a greater number of people to seek treatment. Various sleep medications and devices have flooded the market to help people get adequate rest. With growing health consciousness, more natural products like herbs and supplements are also gaining popularity for sleep promotion. The sleep aids market is expected to further grow at a notable rate in the coming years on the back of ongoing research and development leading to innovations as well as increasing demand from emerging countries.

Market Dynamics:

The global sleep aids market is driven by the rising prevalence of sleep disorders mainly due to changing dietary patterns, busy lifestyles, and increasing stress levels. Sleep deprivation is linked to numerous health issues like obesity, heart diseases, and depression which has boosted the adoption of sleep aids. The growing geriatric population which is more prone to sleep disorders also presents a large addressable market for industry players. However, side effects and risks associated with prescription sleep drugs pose a major challenge. Also, preference for alternative therapies in many countries hamper the market revenue growth to some extent. On the other hand, pace of innovation in sleep technology involving wearable devices and mobile apps offer new opportunities. Growing awareness about the consequences of insomnia and improving healthcare infrastructure in emerging nations will further support industry expansion going forward.

Key Features of the Study:

  • This report provides an in-depth analysis of the global sleep aids market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global sleep aids market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this Pfizer Inc., GSK plc, Sommetrics, Inc., Cadwell Industries, Inc., SleepMed, Inc., Natus Medical Incorporated, Therapix Biosciences Ltd, Compumedics Limited, Eisai Co., Ltd., Tris Pharma, Inc., Novartis AG, Idorsia Pharmaceuticals Ltd., ResMed, AstraZeneca.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global sleep aids market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sleep aids market.

Detailed Segmentation-

  • By Product Type:
    • Medications
    • Sleep Apnea Devices
    • Mattresses and Pillows
    • Others
  • By Sleep Disorder:
    • Insomnia
    • Sleep Apnea
    • Restless Legs Syndrome
    • Night Terrors
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Pfizer Inc.
    • GSK plc
    • Sommetrics, Inc.
    • Cadwell Industries, Inc.
    • SleepMed, Inc.
    • Natus Medical Incorporated
    • Therapix Biosciences Ltd
    • Compumedics Limited
    • Eisai Co., Ltd.
    • Tris Pharma, Inc.
    • Novartis AG
    • Idorsia Pharmaceuticals Ltd.
    • ResMed
    • AstraZeneca

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By Sleep Disorder
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Manufacturer Revenue
  • Acquisitions and Partnerships Scenario
  • Product Launches/Approvals
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Sleep Aids Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Sleep Aids Market, By Product Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Medications
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Sleep Apnea Devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Mattresses and Pillows
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Sleep Aids Market, By Sleep Disorder 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Insomnia
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Sleep Apnea
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Restless Legs Syndrome
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Night Terrors
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Sleep Aids Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
      • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
      • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
      • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
      • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Company Profiles
    • Pfizer Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GSK plc
    • Sommetrics, Inc.
    • Cadwell Industries, Inc.
    • SleepMed, Inc.
    • Natus Medical Incorporated
    • Therapix Biosciences Ltd
    • Compumedics Limited
    • Eisai Co., Ltd.
    • Tris Pharma, Inc.
    • Novartis AG
    • Idorsia Pharmaceuticals Ltd.
    • ResMed
    • AstraZeneca

9. Analyst View

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact